# Perineurial Malignant Peripheral Nerve Sheath Tumor of the Cauda Equina: Diagnostic Challenge

**Authors:** Tomonori Kawasaki, Tomoaki Torigoe, Takuya Watanabe, Satoshi Kanno, Masataka Hirasaki, Arisa Kokubo, Kojiro Onohara, Masanori Wako, Tetsuhiro Hagino, Jiro Ichikawa

PMC · DOI: 10.3390/diagnostics15212697 · Diagnostics · 2025-10-24

## TL;DR

A rare case of perineurial MPNST in the cauda equina is presented, highlighting the diagnostic challenges and the importance of early treatment.

## Contribution

This case report adds to the limited literature on perineurial MPNSTs and emphasizes the need for early diagnosis.

## Key findings

- The tumor was initially misdiagnosed due to lack of distinctive imaging features.
- A definitive diagnosis was made after open biopsy two years later.
- Perineurial MPNSTs may have a better prognosis compared to other MPNST subtypes.

## Abstract

Malignant peripheral nerve sheath tumors (MPNSTs) are rare sarcomas with an extremely rare perineurial subtype. Herein, we present a case of a perineurial MPNST in the cauda equina. Clinically and radiologically, a mass extending from within the spinal canal at the L5 level to outside the intervertebral foramen was identified, raising suspicion of a neurogenic tumor as the primary diagnosis. Computed tomography-guided biopsy suggested an intermediate- to low-grade malignancy; however, a definitive diagnosis could not be established. Two years later, worsening neurological symptoms prompted further imaging, which revealed significant tumor growth and bone invasion. Open biopsy was performed to obtain a definitive diagnosis of perineurial MPNST. MPNSTs lack distinctive imaging features and are generally diagnosed based on a combination of radiological and histopathological findings. Although MPNSTs have a poor prognosis, the perineurial subtype is considered to have a relatively favorable outcome. Given these factors, early diagnosis followed by surgical resection or radiation therapy is recommended.

## Full-text entities

- **Diseases:** malignancy (MESH:D009369), MPNST (MESH:D018319), sarcomas (MESH:D012509), neurological symptoms (MESH:D009461)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12610757/full.md

## References

16 references — full list in the complete paper: https://tomesphere.com/paper/PMC12610757/full.md

---
Source: https://tomesphere.com/paper/PMC12610757